Esperion Therapeutics reported $29.61M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Amarin AMRN:US 86.89M 3.75M
Amgen AMGN:US $ 1.33B 99M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Cytokinetics CYTK:US $ 42.72M 9.65M
Daiichi Sankyo 4568:JP 96.37B 8.36B
Eli Lilly And LLY:US $ 1.63B 67.2M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Geron GERN:US $ 7.44M 744K
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Heron Therapeutics HRTX:US $ 32.12M 836K
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Intra Cellular Therapies ITCI:US $ 100.32M 24.86M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
Merk MRK:US $ 2.42B 118M
Minerva Neurosciences NERV:US $ 2.83M 196.19K
Moderna Inc MRNA:US 211M 57M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Pfizer PFE:US $ 3.2B 506M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Puma Biotechnology PBYI:US $ 20.58M 174K
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Seattle Genetics SGEN:US $ 220.26M 46.03M
United Therapeutics UTHR:US $ 141.5M 62.5M
Vanda Pharmaceuticals VNDA:US $ 33M 7.85M